Inclusion Criteria:
  -  Patients aged 18-74, receiving therapy for active ulcerative colitis confirmed by Mayo Score assessment, and evidence of colonic inflammation.
Exclusion Criteria:
  -  Evidence of Crohn's disease, indeterminate colitis, or presence of bacterial or parasitic infection.
  -  Patients receiving biologic agents and experimental agents are excluded.